News

USC researchers found that adolescents with higher pre-surgery blood levels of PFAS regained more weight after bariatric surgery than those with lower levels. The study links PFAS exposure to reduced long-term treatment success.

Using artificial intelligence, researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies.

A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled their structures to make them more soluble, while maintaining their effectiveness against drug-resistant parasites.

Scientists have developed a bio-engineered molecule that uses a natural compound found in citrus fruits to target and treat inflammation.

How archaea compete with and defend themselves against bacteria has revealed new antibacterials that kill bacteria by targeting the peptidoglycan cell wall.

In a Phase 1 clinical trial of an immunotherapy drug, dubbed 2141-V11, of the 12 patients included, 6 patients saw their tumors shrink, including 2 who saw them disappear completely.

Mount Sinai researchers used the Navigation Guide methodology to review 46 studies on prenatal acetaminophen exposure. Higher-quality studies showed a stronger link to autism spectrum disorder and ADHD.

Researchers at MIT have developed novel antibiotics using generative AI, targeting two drug-resistant bacterial pathogens: Neisseria gonorrhoeae and methicillin-resistant Staphylococcus aureus (MRSA).

Taking inspiration from a rare mutation that makes people impervious to viral diseases, a Columbia researcher is developing a therapy that could bestow this superpower on the rest of us.

Results from an international clinical trial found that risdiplam, a drug used to treat the rare neurodegenerative disorder Spinal Muscular Atrophy, is safe and effective in newborns.